Cite Filings / AIDX
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0001139685

  • Emerging growth company

20/20 Biolabs, Inc.

Sign in to watch
Ticker
AIDX
Exchange
Nasdaq
Industry
Services-Testing Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522272107
Phone
+1 240-453-6339
Business address
9430 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD, 20850
Former names
20/20 GeneSystems, Inc., 20/20 GENE SYSTEMS INC
Filings Financials Insiders Search text
All 169 Financials 17 Shareholder Meetings 4 Executive Compensation 16 Insider Trading 17 Beneficial Ownership Interest 5 Business Combinations 13 Public Offerings 31 Securities-based Crowdfunding 23 Regulation A Offering 30 Mutual Funds and ETFs 2 Others 44
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-10-21
  3. DEF 14A Proxy Proxy Statement 2026-06-23
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-03-10
  5. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-03-10
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-02-25

Page 1 of 1 · 5 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…